Hyperglycemia Global Clinical Trials Review, H2, 2011 (Related Reports)

Hyperglycemia Global Clinical Trials Review, H2, 2011


October 11, 2011
90 Pages - SKU: GBDT6620490
License type:
Online Download      US $1,000.00
Global Site License      US $3,000.00
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017
3/27/2014 | published by: GlobalData
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on  |  read more...
$5,995.00
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022
3/27/2014 | published by: GlobalData
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 Summary Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common rheumatic conditions throughout the world.  |  read more...
$3,995.00
Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014 provides data on the Gastroesophageal (GE) Junction Carcinomas clinical trial scenario. This  |  read more...
$2,500.00
Neuroblastoma Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Neuroblastoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2014 provides data on the Neuroblastoma clinical trial scenario. This report provides elemental information and data relating to the  |  read more...
$2,500.00
Malignant Mesothelioma Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight
4/1/2014 | published by: FirstWord
Introduction Approval of Gilead’s once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in  |  read more...
$4,995.00
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Astrocytoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Low-Grade Glioma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014 provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00